Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Carpenter

Showing results (151-160 of 530) with videos related to

Pageof 53
Sort By:
The Journal of Nervous and Mental Disease|February 1, 1981
Treatment-relevant subtypes of schizophreniaW T Carpenter, D W Heinrichs
The Journal of Nervous and Mental Disease|December 1, 1982
The DSM-III diagnosis of schizophrenic-like illness and the clinical pharmacology of psychosisC A Tamminga, W T Carpenter
Schizophrenia Bulletin|January 1, 1983
New drug treatment strategies in schizophrenia: editorial introductionN R Schooler, W T Carpenter
Schizophrenia Bulletin|January 1, 1983
Early intervention, time-limited, targeted pharmacotherapy of schizophreniaW T Carpenter, D W Heinrichs
Lancet (London, England)|August 20, 1983
Melphalan adjuvant therapy in breast cancerJ T Carpenter, W A Maddox
The British Journal of Psychiatry : the Journal of Mental Science|October 21, 2004
Cannabis and psychosisJ I Koenig, W T Carpenter
Psychiatric Services (Washington, D.C.)|May 3, 2008
Lessons to take home from CATIEWilliam T Carpenter, Robert W Buchanan
The New England Journal of Medicine|March 10, 1994
SchizophreniaW T Carpenter, R W Buchanan
The Journal of Nervous and Mental Disease|February 1, 1988
Reactive psychosis. II. Does DSM-III-R define a third psychosis?D A Jauch, W T Carpenter
Schizophrenia Bulletin|July 20, 2007
Identifying unmet therapeutic domains in schizophrenia patients: the early contributions of Wayne Fenton from Chestnut LodgeThomas H McGlashan, William T Carpenter
Pageof 53

Showing results (151-160 of 530) with videos related to

Sort By:
Pageof 53
The Journal of Nervous and Mental Disease|February 1, 1981
Treatment-relevant subtypes of schizophreniaW T Carpenter, D W Heinrichs
The Journal of Nervous and Mental Disease|December 1, 1982
The DSM-III diagnosis of schizophrenic-like illness and the clinical pharmacology of psychosisC A Tamminga, W T Carpenter
Schizophrenia Bulletin|January 1, 1983
New drug treatment strategies in schizophrenia: editorial introductionN R Schooler, W T Carpenter
Schizophrenia Bulletin|January 1, 1983
Early intervention, time-limited, targeted pharmacotherapy of schizophreniaW T Carpenter, D W Heinrichs
Lancet (London, England)|August 20, 1983
Melphalan adjuvant therapy in breast cancerJ T Carpenter, W A Maddox
The British Journal of Psychiatry : the Journal of Mental Science|October 21, 2004
Cannabis and psychosisJ I Koenig, W T Carpenter
Psychiatric Services (Washington, D.C.)|May 3, 2008
Lessons to take home from CATIEWilliam T Carpenter, Robert W Buchanan
The New England Journal of Medicine|March 10, 1994
SchizophreniaW T Carpenter, R W Buchanan
The Journal of Nervous and Mental Disease|February 1, 1988
Reactive psychosis. II. Does DSM-III-R define a third psychosis?D A Jauch, W T Carpenter
Schizophrenia Bulletin|July 20, 2007
Identifying unmet therapeutic domains in schizophrenia patients: the early contributions of Wayne Fenton from Chestnut LodgeThomas H McGlashan, William T Carpenter
Pageof 53